ISCO Stock Quote

ISCO Press Releases, Recent News

• Thursday, August 26, 2010 11:56 AM EST
  ShamrockStocks.com: Lucky Picks of The Day: (OTCBB:TPCS)- (OTCBB:ISCO)- (OTCBB:VCRT)
  Trading Markets - Aug 26, 2010

  www.shamrockstocks.com names (OTCBB: TPCS | PowerRating) Techprecision Corp., (OTCBB: ISCO | PowerRating) International Stem Cell Corp., and (OTCBB: VCRT | PowerRating) Vicor Technologies, Inc. it ...
• Thursday, August 26, 2010 10:31 AM EST
  International Stem Cell Institute Launches Major Adipose Adult Stem Cell Therapy Program—The New Frontier of Medicine is Your Fat
  Business Wire - Aug 26, 2010

  SAN DIEGO--(BUSINESS WIRE)--International Stem Cell Institute (http://www.iStemCelli.com), a worldwide leader in Stem Cell Therapy, today announces the launch of its significant and proprietary ...

  International Stem Cell Institute Launches Major Adipose Adult Stem Cell Therapy Program—The New Frontier of Medicine is Your Fat - SunHerald.com
  
• Thursday, August 26, 2010 9:49 AM EST
  The Zacks Small-Cap Profile features Cytori Therapeutics, Aastrom Biosciences, StemCells and International Stem Cell
  Business Wire - Aug 26, 2010

  CHICAGO--(BUSINESS WIRE)--Today, Zacks Small-Cap Institutional Research (SCIR) features: Cytori Therapeutics (Nasdaq: CYTX), Aastrom Biosciences (Nasdaq: ASTM), StemCells, Inc. (Nasdaq: STEM) and ...

  The Zacks Small-Cap Profileinclude: Aastrom Biosciences, Aastrom Biosciences, StemCells and International Stem Cell - Zacks.com
  
• Thursday, August 26, 2010 7:06 AM EST
  International Stem Cell Corporation Not Adversely Affected by Stem Cell Research Funding Ban
  MarketWatch - Aug 26, 2010

  OCEANSIDE, Calif., Aug 26, 2010 (BUSINESS WIRE) -- International Stem Cell Corporation (OTC:ISCO) , www.internationalstemcell.com, announced today that the recent action of a federal district ...

  Breakthroughstocks.net: EXPLOSIVE news on: (OTCBB:ECOH) - (OTCBB:PTEEF) - (OTCBB:ISCO) - Trading Markets
  ISCO's therapeutic program not affected by stem cell research federal fund ban - News-Medical.net
  
• Sunday, August 22, 2010 7:25 AM EST
  International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs Into Cytovis
  Biomed Middle East - Aug 22, 2010

  International Stem Cell Corporation announced that its stem cell therapeutic programs focused on protective, transparent corneas (CytoCor™) in the front of the eye and the light-sensitive retinal ...

  International Stem Cell Corporation Forms Cytovis(TM) Business Unit For Its Stem Cell-Based Eye Care - PR-USA.net
  ISCO combines its stem cell-based eye care programmes into Cytovis biz unit - pharmabiz.com
  
• Thursday, August 19, 2010 10:30 AM EST
  Breakthroughstocks.net: EXPLOSIVE news on: (OTCBB:ISCO) - (OTCBB:DRSV) - (OTCBB:BMTI)
  Trading Markets - Aug 19, 2010

  www.breakthroughstocks.net names (OTCBB: ISCO | PowerRating) International Stem Cell Corp., (OTCBB: DRSV | PowerRating) Debt Resolve, Inc., and (OTCBB: BMTL | PowerRating) BioMedical Technology ...
• Thursday, August 19, 2010 7:07 AM EST
  International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs into Cytovis(TM)
  MarketWatch - Aug 19, 2010

  OCEANSIDE, Calif., Aug 19, 2010 (BUSINESS WIRE) -- International Stem Cell Corporation (OTC:ISCO) , www.internationalstemcell.com, today announced that its stem cell therapeutic programs focused ...

  International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs Into Cytovis™ - TheStreet.com
  ISCO to formalize eye-based stem cell therapeutic programs into Cytovis - Trading Markets
  4-traders - SunHerald.com - News-Medical.net
• Wednesday, August 11, 2010 12:32 PM EST
  Biotech Stocks; OTCVolumeLeaders.com ($1.00-$2.00): (OTCBB: PBEC), (OTCBB: AMOK), (OTCBB: ISCO), (OTCBB: NNVC)
  InvestorIdeas.com - Aug 11, 2010

  Point Roberts, WA (Investorideas.com Newswire) August 11, 2010 - OTC VOLUME LEADERS reports on the most active trading stocks on the OTCBB. OTC Volume leaders ($1.00-$2.00) include Pacific Blue ...
• Friday, August 06, 2010 3:16 AM EST
  Euroimplant SA Signs Letter of Intent with International Stem Cell Corporation Concerning Co-operation Between the Companies and Distribution of Their Products
  Reuters Key Development - Aug 6, 2010
• Monday, August 02, 2010 2:49 AM EST
  International Stem Cell Corp. and Sristi Biosciences Ink Distribution PACT
  Trading Markets - Aug 2, 2010

  International Stem Cell Corp., via its subsidiary, Lifeline Cell Technology (Lifeline) and Sristi Biosciences have entered into a distribution agreement for the Lifeline brand of human cell ...

  Stem Cell Stocks Injected with Optimistic News - Sumfolio.com